Alecta Tjanstepension Omsesidigt Makes New $99.95 Million Investment in Gilead Sciences, Inc. $GILD

Alecta Tjanstepension Omsesidigt has made a significant new investment of $99.95 million in Gilead Sciences, acquiring 814,325 shares. This investment represents 0.07% ownership of Gilead, whose recent financial results slightly beat expectations, and analysts maintain a “Moderate Buy” rating with an average target price of $157.35. Despite this institutional confidence, insider trading activity shows net selling of 63,000 shares worth approximately $9.24 million over the last 90 days.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin